Drugs / Norethisteronacetat
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02525276 | Aug 2015 → Aug 2018 | metabolic syndrome X | Rigshospitalet, Denmark | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Norethisteronacetat | “Continually estradiol and gestagens - tablets and patches or cyclic estradiol and gestagens - tablets or patches. Including: Drospirenon, Norethisteronacetat, Medroxyprogesteronacetat” NCT02525276 ↗ |
| Route | Oral | “Continually estradiol and gestagens - tablets and patches or cyclic estradiol and gestagens - tablets or patches.” NCT02525276 ↗ |
| Route | Other | “Continually estradiol and gestagens - tablets and patches or cyclic estradiol and gestagens - tablets or patches.” NCT02525276 ↗ |